Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor
about
T lymphocyte expression of complement receptor 2 (CR2/CD21): a role in adhesive cell-cell interactions and dysregulation in a patient with systemic lupus erythematosus (SLE)Transgenic cell lines for detection of animal virusesEpstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptorEstablishment of latent Epstein-Barr virus infection and stable episomal maintenance in murine B-cell lines.Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pairHuman poliovirus receptor gene expression and poliovirus tissue tropism in transgenic mice.Virus receptors: implications for pathogenesis and the design of antiviral agents.Epithelial cell polarization is a determinant in the infectious outcome of immunoglobulin A-mediated entry by Epstein-Barr virus.Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.Characterization of an Epstein-Barr virus receptor on human epithelial cells.Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2.Determination of the role for CD21 during Epstein-Barr virus infection of B-lymphoblastoid cells.Expression of a human cytomegalovirus receptor correlates with infectibility of cells.Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants.Inhibition of Epstein-Barr virus infection in vitro and in vivo by soluble CR2 (CD21) containing two short consensus repeats.Soluble recombinant CR2 (CD21) inhibits Epstein-Barr virus infection.Structure of the Epstein-Barr virus major envelope glycoprotein.Identification of three gp350/220 regions involved in Epstein-Barr virus invasion of host cells.Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice.
P2860
Q24672100-1FCE6F3D-78B5-431D-A1A1-5AA9302BF20CQ27477859-4558B6C6-D490-4018-A550-86EFA255A9E5Q33799317-442AA6FD-9DBF-48B3-99C9-21B6963376DDQ33866311-C01DBEA4-20A0-423C-8A03-7B7500CAAE0FQ34094547-7154522D-081F-434E-A598-F14F015B4887Q34539517-6EC8A38A-0099-4761-AA92-4215F0392EFFQ35366667-23547BE4-FAA0-4B8F-958B-ECBC86BA6821Q35875268-6490C50E-EE43-4DD7-8EE2-DB8081C8A186Q35886960-EF53221B-5902-4D62-AD71-B56D5AE80815Q36231943-C4272DAB-73C4-42B5-8E3F-E37F79C69784Q36357106-D5B14072-65B1-43E9-B57E-2012094CD675Q36623632-03A88DE7-454A-420C-923F-E7331F90488AQ36694813-270BB2E4-15F9-4509-94E8-9CF679BFD08EQ36700868-5AB5D194-EAE6-4FF1-8FFE-66C7F6E730F4Q36700941-39F99AAA-0AED-492F-841A-1CEBFC416BEBQ36802659-510C2691-504C-43C3-ADE8-5A1A2D033C5AQ40214421-119C32D2-7EEB-4267-9BDC-ADD6C01FD623Q40387241-C534ABED-CAC4-4939-8886-C7D7833D0991Q42175087-CD5AD92B-5478-424F-B213-F66C3B2BDF71
P2860
Epstein-Barr virus (EBV) infection of murine L cells expressing recombinant human EBV/C3d receptor
description
1988 nî lūn-bûn
@nan
1988 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@ast
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@en
type
label
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@ast
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@en
prefLabel
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@ast
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@en
P2093
P2860
P356
P1476
Epstein-Barr virus (EBV) infec ...... mbinant human EBV/C3d receptor
@en
P2093
D T Fearon
J C Hickey
J M Ahearn
S D Hayward
P2860
P304
P356
10.1073/PNAS.85.23.9307
P407
P577
1988-12-01T00:00:00Z